Extraadrenal 21-hydroxylation by CYP2C19 and CYP3A4: Effect on 21-hydroxylase Deficiency

Overview

Journal J Clin Endocrinol Metab

Publisher Oxford University Press

Specialty Endocrinology

Date 2008 Oct 30

PMID 18957504

Citations 28

Authors

Larissa G Gomes

Ningwu Huang

Vishal Agrawal

Berenice B Mendonca

Tania A S S Bachega

Walter L Miller

Affiliations

Soon will be listed here.

Abstract

Context: 21-Hydroxylase deficiency (21OHD) is caused by CYP21A2 gene mutations disrupting the adrenal 21-hydroxylase, P450c21. CYP21A2 mutations generally correlate well with the 21OHD phenotype, but some children with severe CYP21A2 mutations have residual 21-hydroxylase activity. Some hepatic P450 enzymes can 21-hydroxylate progesterone, but their physiological relevance in modifying 21OHD is not known.

Objective: We determined the ability of CYP2C19 and CYP3A4 to 21-hydroxylate progesterone and 17-hydroxyprogesterone (17OHP), determined the impact of the common P450 oxidoreductase (POR) variant A503V on these activities, and examined correlations between CYP2C19 variants and phenotype in patients with 21OHD.

Methods: Bacterially expressed, N-terminally modified, C-His-tagged human P450c21, CYP2C19, and CYP3A4 were combined with bacterially expressed wild-type and A503V POR. The 21-hydroxylation of radiolabeled progesterone and 17OHP was assessed, and the Michaelis constant (Km) and maximum velocity (Vmax) of the reactions were measured. CYP2C19 was genotyped in 21OHD patients with genotypes predicting severe congenital adrenal hyperplasia.

Results: Compared to P450c21, the Vmax/Km for 21-hydroxylation of progesterone by CYP2C19 and CYP3A4 were 17 and 10%, respectively. With both forms of POR, the Km for P450c21 was approximately 2.6 microm, the Km for CYP2C19 was approximately 11 microm, and the Km for CYP3A4 was approximately 110 microm. Neither CYP2C19 nor CYP3A4 could 21-hydroxylate 17OHP. The CYP2C19 ultrametabolizer allele CYP2C19 17 was homozygous in one of five patients with a 21OHD phenotype that was milder than predicted by the CYP21A2 genotype.

Conclusions: CYP2C19 and CYP3A4 can 21-hydroxylate progesterone but not 17OHP, possibly ameliorating mineralocorticoid deficiency, but not glucocorticoid deficiency. Multiple enzymes probably contribute to extraadrenal 21-hydroxylation.

Citing Articles

Genetics in Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency and Clinical Implications.

Concolino P, Falhammar H J Endocr Soc. 2025; 9(3):bvaf018.

PMID: 39911519 PMC: 11795198. DOI: 10.1210/jendso/bvaf018.

Catalytic enhancements in cytochrome P450 2C19 by cytochrome .

Lee G, Kim V, Lee S, Jeong E, Kim C, Lee Y Toxicol Res. 2024; 40(2):215-222.

PMID: 38525137 PMC: 10959859. DOI: 10.1007/s43188-023-00219-8.

Interpretation of Steroid Biomarkers in 21-Hydroxylase Deficiency and Their Use in Disease Management.

Sarafoglou K, Merke D, Reisch N, Claahsen-van der Grinten H, Falhammar H, Auchus R J Clin Endocrinol Metab. 2023; 108(9):2154-2175.

PMID: 36950738 PMC: 10438890. DOI: 10.1210/clinem/dgad134.

Progesterone: A Steroid with Wide Range of Effects in Physiology as Well as Human Medicine.

Kolatorova L, Vitku J, Suchopar J, Hill M, Parizek A Int J Mol Sci. 2022; 23(14).

PMID: 35887338 PMC: 9322133. DOI: 10.3390/ijms23147989.

Molecular Diagnosis of Steroid 21-Hydroxylase Deficiency: A Practical Approach.

Arriba M, Ezquieta B Front Endocrinol (Lausanne). 2022; 13:834549.

PMID: 35422767 PMC: 9001848. DOI: 10.3389/fendo.2022.834549.

References

Mellon S, Miller W . Extraadrenal steroid 21-hydroxylation is not mediated by P450c21. J Clin Invest. 1989; 84(5):1497-502. PMC: 304014. DOI: 10.1172/JCI114325. View

Swinney D, Ryan D, Thomas P, Levin W . Regioselective progesterone hydroxylation catalyzed by eleven rat hepatic cytochrome P-450 isozymes. Biochemistry. 1987; 26(22):7073-83. DOI: 10.1021/bi00396a032. View

Chiou S, Hu M, Chung B . A missense mutation at Ile172----Asn or Arg356----Trp causes steroid 21-hydroxylase deficiency. J Biol Chem. 1990; 265(6):3549-52. View

Tusie-Luna M, Traktman P, White P . Determination of functional effects of mutations in the steroid 21-hydroxylase gene (CYP21) using recombinant vaccinia virus. J Biol Chem. 1990; 265(34):20916-22. View

Speiser P, Agdere L, Ueshiba H, White P, New M . Aldosterone synthesis in salt-wasting congenital adrenal hyperplasia with complete absence of adrenal 21-hydroxylase. N Engl J Med. 1991; 324(3):145-9. DOI: 10.1056/NEJM199101173240302. View

Higashi Y, Hiromasa T, TANAE A, Miki T, Nakura J, Kondo T . Effects of individual mutations in the P-450(C21) pseudogene on the P-450(C21) activity and their distribution in the patient genomes of congenital steroid 21-hydroxylase deficiency. J Biochem. 1991; 109(4):638-44. DOI: 10.1093/oxfordjournals.jbchem.a123433. View

Fisher C, Caudle D, Quattrochi L, Tukey R, Waterman M, Estabrook R . High-level expression of functional human cytochrome P450 1A2 in Escherichia coli. FASEB J. 1992; 6(2):759-64. DOI: 10.1096/fasebj.6.2.1537466. View

Speiser P, Dupont J, Zhu D, Serrat J, Buegeleisen M, Tusie-Luna M . Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Invest. 1992; 90(2):584-95. PMC: 443137. DOI: 10.1172/JCI115897. View

Murray M . Participation of a cytochrome P450 enzyme from the 2C subfamily in progesterone 21-hydroxylation in sheep liver. J Steroid Biochem Mol Biol. 1992; 43(6):591-3. DOI: 10.1016/0960-0760(92)90248-h. View

10.

Wedell A, Luthman H . Steroid 21-hydroxylase deficiency: two additional mutations in salt-wasting disease and rapid screening of disease-causing mutations. Hum Mol Genet. 1993; 2(5):499-504. DOI: 10.1093/hmg/2.5.499. View

11.

Wilson R, Mercado A, Cheng K, New M . Steroid 21-hydroxylase deficiency: genotype may not predict phenotype. J Clin Endocrinol Metab. 1995; 80(8):2322-9. DOI: 10.1210/jcem.80.8.7629224. View

12.

Yamazaki H, Shimada T . Progesterone and testosterone hydroxylation by cytochromes P450 2C19, 2C9, and 3A4 in human liver microsomes. Arch Biochem Biophys. 1997; 346(1):161-9. DOI: 10.1006/abbi.1997.0302. View

13.

Therrell Jr B, Berenbaum S, Simmank J, Korman K, Prentice L, Gonzalez J . Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia. Pediatrics. 1998; 101(4 Pt 1):583-90. DOI: 10.1542/peds.101.4.583. View

14.

Bachega T, Billerbeck A, Madureira G, Marcondes J, Longui C, Leite M . Molecular genotyping in Brazilian patients with the classical and nonclassical forms of 21-hydroxylase deficiency. J Clin Endocrinol Metab. 1998; 83(12):4416-9. DOI: 10.1210/jcem.83.12.5350. View

15.

Bachega T, Billerbeck A, Madureira G, Arnhold I, Medeiros M, Marcondes J . Low frequency of CYP2B deletions in Brazilian patients with congenital adrenal hyperplasia due to 21-hydroxylas deficiency. Hum Hered. 1999; 49(1):9-14. DOI: 10.1159/000022833. View

16.

Huang N, Pandey A, Agrawal V, Reardon W, Lapunzina P, Mowat D . Diversity and function of mutations in p450 oxidoreductase in patients with Antley-Bixler syndrome and disordered steroidogenesis. Am J Hum Genet. 2005; 76(5):729-49. PMC: 1199364. DOI: 10.1086/429417. View

17.

Pandey A, Miller W . Regulation of 17,20 lyase activity by cytochrome b5 and by serine phosphorylation of P450c17. J Biol Chem. 2005; 280(14):13265-71. DOI: 10.1074/jbc.M414673200. View

18.

Miller W . Minireview: regulation of steroidogenesis by electron transfer. Endocrinology. 2005; 146(6):2544-50. DOI: 10.1210/en.2005-0096. View

19.

Dolzan V, Solyom J, Fekete G, KOVACS J, Rakosnikova V, Votava F . Mutational spectrum of steroid 21-hydroxylase and the genotype-phenotype association in Middle European patients with congenital adrenal hyperplasia. Eur J Endocrinol. 2005; 153(1):99-106. DOI: 10.1530/eje.1.01944. View

20.

Sim S, Risinger C, Dahl M, Aklillu E, Christensen M, Bertilsson L . A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants. Clin Pharmacol Ther. 2006; 79(1):103-13. DOI: 10.1016/j.clpt.2005.10.002. View